SAR 4

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/49

encourage image

There's no tags or description

Looks like no tags are added yet.

50 Terms

1
New cards

pharmacotherapy

to obtain therapeutic effect without (minimal) side effects for a desired duration

2
New cards

pharmacokinetics

study and mathematical characterization of the time course of drug absorption, distribution, metabolism, and excretion processes that determine the time course of drug conc

3
New cards

pharmacodynamics

quantitative analysis of the intensity and time course of pharmacological effects based on the mechanism of action of the drug and concentration effect relationships

4
New cards

successful pharmacotherapy

understanding and controlling of both PK and PD of drug is essential

5
New cards

in vitro

technique of performing a given procedure in a controlled environment outside of a living organism

6
New cards

within the glass

in vitro

7
New cards

in vivo

experimentation using a whole, living organism as opposed to a partial or dead organism. animal studies and clinical trials

8
New cards

within the living

in vivo

9
New cards

in silico

preformed on computer or via computer simulation

10
New cards

in vitro drug conc

drug dose/ volume of media

11
New cards

in vivo drug conc at the target

F (dose, ADME)

to bind to receptors in the site of action, sufficient drug conc should reach the targets from the site of administration

12
New cards

drug exposure

measure as time dependent plasma concentration curve

13
New cards

plasma

used as a surrogate because difficult to collect tissues of disease in clinical settings/trials. drug is equilibrated ibetween plasma and target tissue

14
New cards

first pass effect

drug metabolism where the conc of drug is greatly reduced before it reaches the systemic circulation

15
New cards

effective drugs

reach the site of action (absorbed and distributed) and interact with their targets for enough time

16
New cards

barriers and targets

anatomical barriers, chemical barriers, biochemical barriers and targets

17
New cards

anatomical barriers

membranes

18
New cards

chemical barriers

body fluid, ph, solubility and ionization

19
New cards

biochemical barriers and targets

transporters, enzymes, and receptors

20
New cards

dissolution

rate limiting step in absorption of some oral solid dosage forms

21
New cards

2 different formulations

2 different dissolution rates, 2 different onset times and duration of actions

22
New cards

function of log C

relationship with pharmacological activity produces a sigmoidal curve pattern

23
New cards

drug plasma conc

driving force for drug activity/response, response is dependent on conc, time course of response depends on time course of conc

24
New cards

MSC

maximum safe conc

25
New cards

MEC

minimum effective conc

26
New cards

time course

after multiple dosing it can be simulated based on after single dosing, IV and PO dive two distinct patterns

27
New cards

time course parameters

Vd, CL, F, Co, Cmax, AUC, Tmax

28
New cards

Vd

volume of distribution

29
New cards

CL

clearance

30
New cards

A

absorption

31
New cards

F

fraction absorbed (bioavailability

32
New cards

dose and frequency

can be determined from half life and bioavailability

33
New cards

bioavailability (F)

fraction of initial dose that reaches the circulation after the first-pass effect (secondary dependent parameter)

34
New cards

F equation

=AUC oral/ AUC iv

35
New cards

volume of distribution

proportionality constant that relates the amount of drug in the body (A) with the measured plasma concentration

volume that would be necessary to contain the total amount of an administered drug at the same concentration that it is observed in the blood plasma

36
New cards

Vd usage

determines how readily the drug will displace into the body tissue compartments relative to the blood

37
New cards

higher Vd

greater amount of tissue distribution

typically drugs with high lipid solubility, low rates of ionization, weak basic groups, or low plasma protein binding capabilities

38
New cards

clearance

volume of plasma from which drug is totally remoced over a specific period of time

39
New cards

major clearing routes

metabolic, renal, biliary

40
New cards

total drug clearance

additive, equal to the sum of all clearance routes

41
New cards

methods of PK modeling

compartment models, PBPK (physiologically based PK models)

42
New cards

compartment models

simulate ADE

flow= rate constant K

compartment= group of tissue with a similar blood flow and affinity for the drug

43
New cards

PBPK

a kind of compartment model but each compartment represents an actual tissue and an organ space

flow=real blood flow Q

compartment=real tissue

44
New cards

occupancy theory

apply law of mass action to the relationship between concentration and target occupancy

45
New cards

receptor occupancy theory

assumed response is directly proportional to occupancy

46
New cards

hill equation

reflects the law of mass action, useful in quantitative pharmacology

limited conc/capacity of receptors or limitations in physiological systems produce nonlinear concentration vs response profiles

47
New cards

DMPK liabilities

low potency/selectivity

poor solubility

low Papp, high ER

low oral bioavailability

high clearance

low metabolic stability

CYP inhibition

48
New cards

DMPK

examine how the body handles a drug and help select better drug candidates early in development, identify potential issues early to improve safety and effectiveness

49
New cards

DMPK goals

optimize drug properties- absorption, bioavailability, clearance, half life, metabolic stability, protein binding

minimize potential problems- drug interactions, enzyme induction/inhibition, first pass metabolism, differences in metabolism bc of genetics

50
New cards

lead optimization through structure modification

improve potency and selectivity, achieve desired ADMET properties based on SAR and SPR analysis